- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in Covaxin
Covaxin Gets Emergency Use Authorisation For Children Aged 6-12: Sources
The development comes after the Subject Expert Committee (SEC) of the DCGI asked Bharat Biotech for additional data on Covaxin, for administering it to children aged between 2-12 years, sources said
Read More
Covaxin Booster Amplifies Protection Against Variants Of Concern: ICMR Study
As a part of the study the antibody responses in sera of 51 participants who received two doses of Covaxin collected six months post second dose and 28 days after receiving a third (booster) dose (given on day 215th post second dose) and its impact against the Omicron VoC was evaluated
Read More
Covishield And Covaxin Doses To Cost Rs 225 Now In Private Hospitals
The Serum Institute of India has cut the rates of Covishield from ₹600 to ₹225 per dose, while Bharat Biotech has brought down the price of Covaxin from ₹1,200 to ₹225
Read More
India's Expert Panel Advises Full Approval For Covishield, Covaxin
Covaxin and Covishield received emergency use authorisation in India in January 2021, with more than a combined 1.5 billion doses having been administered so far, according to government data.
Read More
Govt Expert Panel Recommends Regular Market Approval For Covishield, Covaxin
Pharma companies Serum Institute of India (SII) and Bharat Biotech had submitted applications to the Drugs Controller General of India (DCGI) seeking regular market authorisation for their respective COVID-19 vaccines Covishield and Covaxin.
Read More
Covaxin Shows 50% Effectiveness Against Symptomatic COVID-19 In Real-World Assessment: Lancet Study
The COVID-19 vaccination centre at AIIMS New Delhi exclusively offered Covaxin beginning January 16 this year to all of its 23,000 employees.
Read More
Covaxin 77.8% Effective Against COVID-19: Lancet Study
The efficacy analysis demonstrated that Covaxin to be 93.4 per cent effective against severe symptomatic Covid-19.
Read More
WHO Approval To Covaxin Will Improve Ease Of Travel For Vaccinated Indians: MEA
MEA Spokesperson Arindam Bagchi said 96 countries have either accepted WHO-approved vaccines, which would include both Covishield and Covaxin, or in some cases only Covishield or Covaxin.
Read More
UK To Add India's Covaxin To Approved Vaccine List For Inbound Travellers
The move follows the World Health Organisation's (WHO) Emergency Use Listing for Covaxin, which is the second most used formulation in India.
Read More
Bharat Biotech's Partner Ocugen Files EUA Request With FDA For Paediatric Use Of Covaxin
Having a new type of vaccine available will enable people to discuss with their child's physician the best approach for them to lower their child's risk of contracting COVID-19
Read More
Bharat Biotech To Produce 700 Mn Covaxin Doses Annually
According to a press release issued by the Hyderabad-based vaccine maker, manufacturing scale-up has been carried out in a stepwise manner across multiple facilities at Hyderabad and Bangalore.
Read More
COVID Vaccine Approval Procedure Takes Longer Time: WHO official, As Covaxin decision awaited
Ryan was responding to a question during a recent virtual Q&A on whether there will be a definitive answer on Covaxin EUL by October 26.
Read More
WHO's Technical Group To Meet On Oct 26 To Consider Emergency Use Listing Of Covaxin
The WHO experts are currently reviewing this information and if it addresses all questions raised, the WHO assessment will be finalised next week.
Read More
WHO To Take Final Decision Next Week On Approval To Bharat Biotech's Covaxin
WHO experts are currently reviewing this info & if it addresses all questions raised, WHO assessment will be finalized next week, WHO said in a series of tweets.
Read More
Centre Got Over 65.25 Crore Covishield Doses, 9.1 Crore Covaxin Jabs Till September 19
The SII has informed the government that it will be able to supply around 22 crore doses of Covishield in October.
Read More